Your browser doesn't support javascript.
loading
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
Lundgren, Anna; Bourgeois, Louis; Carlin, Nils; Clements, John; Gustafsson, Björn; Hartford, Marianne; Holmgren, Jan; Petzold, Max; Walker, Richard; Svennerholm, Ann-Mari.
Afiliação
  • Lundgren A; University of Gothenburg Vaccine Research Institute (GUVAX), Dept. of Microbiology and Immunology, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden. Electronic address: anna.lundgren@microbio.gu.se.
  • Bourgeois L; PATH, 455 Massachusetts Ave, NW, WA, DC 20001, USA. Electronic address: lbourgeois@path.org.
  • Carlin N; Scandinavian Biopharma, Gunnar Asplunds allé 16, 171 63 Solna, Sweden. Electronic address: nils.carlin@etvax.se.
  • Clements J; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: jclemen@tulane.edu.
  • Gustafsson B; Scandinavian Biopharma, Gunnar Asplunds allé 16, 171 63 Solna, Sweden. Electronic address: bjorn.gustafsson@etvax.se.
  • Hartford M; Clinical Trial Center, Sahlgrenska University Hospital, Gröna stråket 12, 413 45 Gothenburg, Sweden. Electronic address: amhgbg@gmail.com.
  • Holmgren J; University of Gothenburg Vaccine Research Institute (GUVAX), Dept. of Microbiology and Immunology, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden. Electronic address: jan.holmgren@microbio.gu.se.
  • Petzold M; Centre for Applied Biostatistics, Sahlgrenska Academy, University of Gothenburg, Box 414, 405 30 Gothenburg, Sweden. Electronic address: max.petzold@gu.se.
  • Walker R; PATH, 455 Massachusetts Ave, NW, WA, DC 20001, USA. Electronic address: rwalker@path.org.
  • Svennerholm AM; University of Gothenburg Vaccine Research Institute (GUVAX), Dept. of Microbiology and Immunology, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden. Electronic address: ann-mari.svennerholm@microbio.gu.se.
Vaccine ; 32(52): 7077-84, 2014 Dec 12.
Article em En | MEDLINE | ID: mdl-25444830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Vacinas contra Escherichia coli / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Vacinas contra Escherichia coli / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Vaccine Ano de publicação: 2014 Tipo de documento: Article